Tiglutik

Recent Posts

• Relyvrio, Radicava ORS Cost-effective at Current Prices: ICER
• ‘Good Enough’ Means Something Different in Life With ALS
• uniQure Acquires Rights to Develop APB-102
• Cytokinetics’ Communications Grants Awarded to 2 ALS Groups
• New Pig Model May Better Capture ALS at Its Earliest Stages